4//SEC Filing
Stenhouse Mark 4
Accession 0001209191-22-031169
CIK 0001718852other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:15 PM ET
Size
5.5 KB
Accession
0001209191-22-031169
Insider Transaction Report
Form 4
Stenhouse Mark
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-20+86,582→ 86,582 totalExercise: $29.56From: 2025-05-20Exp: 2032-05-19→ Common Stock (86,582 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the third anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.
Documents
Issuer
Prometheus Biosciences, Inc.
CIK 0001718852
Entity typeother
Related Parties
1- filerCIK 0001734751
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:15 PM ET
- Size
- 5.5 KB